Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aiming at enhancing antitumor immunity. Their clinical efficacy is well-documented, but the side effects associated with their use are still under investigation. These drugs cause several immune-related ad...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Melissaropoulos, Konstantinos, Klavdianou, Kalliopi, Filippopoulou, Alexandra, Kalofonou, Fotini, Kalofonos, Haralabos, Daoussis, Dimitrios
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247001/
https://ncbi.nlm.nih.gov/pubmed/32403289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093389
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items